Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...
The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.
Popular brands such as Ozempic, Wegovy and Mounjaro were initially approved by the U.S. Food and Drug Administration to ...
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...
The discovery was reported in the journal Nature and could lead to a new therapy for millions of people with both obesity and ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...
Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to ...
The discovery could lead to a new treatment for millions of people with obesity and type 2 diabetes who do not respond well ...
The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...